Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp

Name: Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp
Published: 2021
License: Public Domain

Biofrontera Bioscience GmbH · 2021

ClinicalTrials.gov · Datasets · License: Public Domain · 2021

Open Source ↗

photodynamic-therapy

actinic keratosis, keratosis, actinic, keratosis, photodynamic therapy, 5-aminolevulinic acid, photosensitizing agents, dermatologic agents, precancerous condition, skin disease, interventional, phase1

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Study to Evaluate Safety and Tolerability of BF-200 ALA (Ameluz®) for Photodynamic Therapy in the Treatment of the Expanded Field of Actinic Keratosis on Face and Scalp

Related documents